Blueprint Medicines

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch BPMC and buy or sell other stocks, ETFs, and their options commission-free!

About BPMC

Blueprint Medicines develops targeted therapies for cancer and blood disorders, focusing on precision medicine. The company utilizes genetic insights to design treatments tailored to individual patient needs. 

CEO
Kathryn Haviland, MBA
CEOKathryn Haviland, MBA
Employees
649
Employees649
Headquarters
Cambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded
2008
Founded2008
Employees
649
Employees649

BPMC Key Statistics

Market cap
8.36B
Market cap8.36B
Price-Earnings ratio
-52.60
Price-Earnings ratio-52.60
Dividend yield
—
Dividend yield—
Average volume
298.10K
Average volume298.10K
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
$129.64
52 Week high$129.64
52 Week low
$73.13
52 Week low$73.13

People also own

Based on the portfolios of people who own BPMC. This list is generated using Robinhood data, and it’s not a recommendation.
Microsoft
AMD
Alibaba
Meta Platforms
Disney
Uber
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.